Francisco Afrânio Cunha

Francisco Afrânio Cunha

Auto-generated profile, based on publicly available information

Francisco Afrânio Cunha

Universidade Federal do Ceará

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2015 in Revista do Instituto de Medicina Tropical de São Paulo
Verified
Journal Article
Open access
PDF file
EMEduardo José J. Mallmann
Eduardo José J. Mallmann
FCFrancisco Afrânio Cunha
Francisco Afrânio Cunha
BCBruno N.M.F. Castro
Bruno N.M.F. Castro
AMAuberson Martins Maciel
Auberson Martins Maciel
EMEverardo Albuquerque Menezes
Everardo Albuquerque Menezes
PFPierre Fechine
Pierre Fechine
Silver nanoparticles (AgNPs) are metal structures at the nanoscale. AgNPs have exhibited antimicrobial activities against fungi and bacteria; however synthesis of AgNPs can generate toxic waste during the reaction process. Accordingly, new routes using non-toxic compounds have been researched. The proposal of the present study was to synthesize AgNPs using ribose as a reducing agent and sodium dodecyl sulfate (SDS) as a stabilizer. The antifungal activity of these particles against C. albicans and C. tropicalis was also evaluated. Stable nanoparticles 12.5 ± 4.9 nm (mean ± SD) in size were obtained, which showed high activity against Candida spp. and could represent an alternative for fungal infection treatment.

21 January 2013 in Journal of Essential Oil Research
Verified
Journal Article
Closed access
ILIgara Oliveira Lima
Igara Oliveira Lima
Fillipe de Oliveira PereiraFillipe de Oliveira Pereira
Fillipe de Oliveira Pereira
WOWylly Araújo de Oliveira
Wylly Araújo de Oliveira
ELEdeltrudes de Oliveira Lima
Edeltrudes de Oliveira Lima
EMEverardo Albuquerque Menezes
Everardo Albuquerque Menezes
MDMargareth de Fátima Formiga Melo Diniz
Margareth de Fátima Formiga Melo Diniz
In this study, the minimal inhibitory concentration (MIC), minimal fungicidal concentration (MFC) and mode of action of carvacrol were determined. MIC was determined according to the standard broth microdilution method, and MFC was taken as the lowest concentration in culture plates with Sabouraud dextrose agar, at which growth was less than 3 CFU. The effect of ergosterol or sorbitol on carvacrol was investigated using the broth microdilution method. MIC was 256 μg/mL and MFC was 512 μg/mL. This phytoconstituent acts by binding to sterols in the fungal membrane and does not act by modifying the fungal cell wall. This study is important because it shows the mode of action of carvacrol. However, more studies are necessary to define the exact mechanism of action.

1 January 2016 in Revista do Instituto de Medicina Tropical de São Paulo
Verified
Journal Article
Open access
PDF file
FCFrancisco Afrânio Cunha
Francisco Afrânio Cunha
KMKamila Rocha Maia
Kamila Rocha Maia
EMEduardo José Jucá Mallman
Eduardo José Jucá Mallman
MCMaria da Conceição dos Santos Oliveira Cunha
Maria da Conceição dos Santos Oliveira Cunha
AMAntonio Auberson Martins Maciel
Antonio Auberson Martins Maciel
PFPierre Fechine
Pierre Fechine
Nanotechnology can be a valuable ally in the treatment of infections. Silver nanoparticles (AgNPs) are structures that have antimicrobial activity. The aim of this study was to produce AgNPs by green methods, characterize these structures, and assess their antimicrobial activity against Escherichia coli associated with the antibiotic ciprofloxacin. AgNPs were characterized by spectroscopic and microscopic techniques. Antimicrobial activity was evaluated by the disk diffusion method against 10 strains of E. coli. The synthesized AgNPs showed a spherical shape and a size of 85.07 ± 12.86 nm (mean ± SD). AgNPs increased the activity of ciprofloxacin by 40% and may represent a new therapeutic option for the treatment of bacterial infections.

1 August 2012 in Revista do Instituto de Medicina Tropical de São Paulo
Verified
Journal Article
Open access
PDF file
EMEverardo Albuquerque Menezes
Everardo Albuquerque Menezes
AJAntonio Alexandre de Vasconcelos Junior
Antonio Alexandre de Vasconcelos Junior
CSCarlla Lorena Façanha Silva
Carlla Lorena Façanha Silva
FPFábio Ximenes Plutarco
Fábio Ximenes Plutarco
MCMaria da Conceição dos Santos Oliveira Cunha
Maria da Conceição dos Santos Oliveira Cunha
FCFrancisco Afrânio Cunha
Francisco Afrânio Cunha
Systemic fungal infections are responsible for high mortality rates. Several species of fungi may be involved, but Candida spp. is the most prevalent. Simvastatin is used to lower cholesterol and also exhibits antifungal action. The aim of this study was to evaluate the synergistic action of simvastatin with fluconazole against strains of Candida spp. Susceptibility testing was performed according to protocol M27-A3, by broth microdilution method and the synergistic effect of simvastatin and fluconazole was calculated based on FICI (Fractional Inhibitory Concentration Index). Eleven strains were evaluated, and simvastatin showed a synergistic effect with fluconazole against 10 (91%) of the Candida spp. strains tested. Simvastatin may be a valuable drug in the treatment of systemic infections caused by Candida spp.

1 February 2012 in Revista do Instituto de Medicina Tropical de São Paulo
Verified
Journal Article
Open access
PDF file
EMEverardo Albuquerque Menezes
Everardo Albuquerque Menezes
JMJosé Arlécio de Sousa Marinho
José Arlécio de Sousa Marinho
MAMaria Rozzelê F. Angelo
Maria Rozzelê F. Angelo
MCMaria da Conceição dos Santos Oliveira Cunha
Maria da Conceição dos Santos Oliveira Cunha
FCFrancisco Afrânio Cunha
Francisco Afrânio Cunha
AJAntonio Alexandre de Vasconcelos Junior
Antonio Alexandre de Vasconcelos Junior
Trichosporon spp. are yeasts capable of causing invasive disease, which mainly affect immunocompromised patients. A clinical strain of T. asahii was isolated from the blood cultures of patients admitted to the General Hospital of Fortaleza. Susceptibility tests were conducted by disk diffusion and broth microdilution. The isolated strain of T. asahii was resistant to fluconazole. The patient used amphotericin B and caspofungin in order to facilitate the microbiological cure. It was the first isolation and identification of T. asahii in blood culture in Ceará, Brazil.

17 May 2017 in The Journal of Physical Chemistry C
Verified
Journal Article
Closed access
VNVictor T. Noronha
Victor T. Noronha
FSFrancisco A. Sousa
Francisco A. Sousa
AFAntonio G. Souza Filho
Antonio G. Souza Filho
CSCristiane A. Silva
Cristiane A. Silva
FCFrancisco A. Cunha
Francisco A. Cunha
APAmauri J. Paula
Amauri J. Paula